358 related articles for article (PubMed ID: 16982235)
1. Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion: a randomized trial.
Carbonell Esteve JL; Marí JM; Valero F; Llorente M; Salvador I; Varela L; Leal P; Candel A; Tudela A; Serrano M; Muñoz E
Contraception; 2006 Oct; 74(4):328-33. PubMed ID: 16982235
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
Hamoda H; Ashok PW; Flett GM; Templeton A
Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
[TBL] [Abstract][Full Text] [Related]
3. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
Caliskan E; Filiz T; Yucesoy G; Coskun E; Vural B; Corakci A
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
[TBL] [Abstract][Full Text] [Related]
4. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
Tang OS; Mok KH; Ho PC
Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
6. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia.
Saxena P; Sarda N; Salhan S; Nandan D
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):101-6. PubMed ID: 18275580
[TBL] [Abstract][Full Text] [Related]
7. Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial.
Carbonell JL; Velazco A; Rodriguez Y; Tanda R; Sánchez C; Barambio S; Valera L; Chami S; Valero F; Aragón S; Marí J
Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):134-40. PubMed ID: 11763976
[TBL] [Abstract][Full Text] [Related]
8. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
[TBL] [Abstract][Full Text] [Related]
9. Sublingual versus vaginal route of misoprostol for cervical ripening prior to surgical termination of first trimester abortions.
Saxena P; Salhan S; Sarda N
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):109-13. PubMed ID: 16139942
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy.
Vimala N; Mittal S; Kumar S; Dadhwal V; Sharma Y
Contraception; 2004 Aug; 70(2):117-20. PubMed ID: 15288215
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy.
Ashok PW; Hamoda H; Nathani F; Flett GM; Templeton A
BJOG; 2003 Dec; 110(12):1057-61. PubMed ID: 14664876
[TBL] [Abstract][Full Text] [Related]
14. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
Tang OS; Lau WN; Chan CC; Ho PC
BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol.
Colón I; Clawson K; Hunter K; Druzin ML; Taslimi MM
Am J Obstet Gynecol; 2005 Mar; 192(3):747-52. PubMed ID: 15746667
[TBL] [Abstract][Full Text] [Related]
18. Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparison.
Aronsson A; Helström L; Gemzell-Danielsson K
Contraception; 2004 Feb; 69(2):165-9. PubMed ID: 14759623
[TBL] [Abstract][Full Text] [Related]
19. Oral versus vaginal misoprostol administered one hour before surgical termination of pregnancy: a randomised controlled trial.
Sharma S; Refaey H; Stafford M; Purkayastha S; Parry M; Axby H
BJOG; 2005 Apr; 112(4):456-60. PubMed ID: 15777444
[TBL] [Abstract][Full Text] [Related]
20. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
